Comment
doi: 10.1016/S2213-2600(15)00258-1.
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?
Affiliations
- PMID: 26282478
- DOI: 10.1016/S2213-2600(15)00258-1
Item in Clipboard
Comment
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?
Lancet Respir Med.
2015 Aug.
No abstract available
Comment in
-
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?--Authors' reply.Lancet Respir Med. 2015 Aug;3(8):e27. doi: 10.1016/S2213-2600(15)00259-3. Lancet Respir Med. 2015. PMID: 26282479 No abstract available.
Comment on
-
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Lancet Respir Med. 2015. PMID: 25878028 Clinical Trial.
Similar articles
-
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?--Authors' reply.Lancet Respir Med. 2015 Aug;3(8):e27. doi: 10.1016/S2213-2600(15)00259-3. Lancet Respir Med. 2015. PMID: 26282479 No abstract available.
-
Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts.Lancet Respir Med. 2015 Jun;3(6):416-7. doi: 10.1016/S2213-2600(15)00145-9. Epub 2015 Apr 16. Lancet Respir Med. 2015. PMID: 25892351 No abstract available.
-
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Lancet Respir Med. 2015. PMID: 25878028 Clinical Trial.
-
Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.Med Lett Drugs Ther. 2013 Sep 2;55(1424):69-71, 45-8. Med Lett Drugs Ther. 2013. PMID: 26839934 Review. English, French. No abstract available.
-
Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.Ann Pharmacother. 2014 Feb;48(2):250-7. doi: 10.1177/1060028013512615. Epub 2013 Nov 19. Ann Pharmacother. 2014. PMID: 24259654 Review.
Cited by
-
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1191-1199. doi: 10.1002/pds.4655. Epub 2018 Sep 28. Pharmacoepidemiol Drug Saf. 2018. PMID: 30264901 Free PMC article.
-
Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.BMC Pulm Med. 2020 Feb 24;20(1):50. doi: 10.1186/s12890-020-1086-1. BMC Pulm Med. 2020. PMID: 32093672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
